Home
>
National Drug Code (NDC)
>
Ribavirin
Ribavirin - 68382-260-07 - (Ribavirin)
Drug Information of Ribavirin
| Product NDC: | 68382-260 |
| Proprietary Name: | Ribavirin |
| Non Proprietary Name: | Ribavirin |
| Active Ingredient(s): | 200 mg/1 & nbsp; Ribavirin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ribavirin
| Product NDC: | 68382-260 |
| Labeler Name: | Zydus Pharmaceuticals (USA) Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077224 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060125 |
Package Information of Ribavirin
| Package NDC: | 68382-260-07 |
| Package Description: | 56 CAPSULE in 1 BOTTLE (68382-260-07) |
NDC Information of Ribavirin
| NDC Code | 68382-260-07 |
| Proprietary Name | Ribavirin |
| Package Description | 56 CAPSULE in 1 BOTTLE (68382-260-07) |
| Product NDC | 68382-260 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ribavirin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20060125 |
| Marketing Category Name | ANDA |
| Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
| Substance Name | RIBAVIRIN |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
